Three Pharma Companies in Focus: Apollo Hospitals, Abbott, and Piramal Pharma

Apollo Hospitals Enterprises faces a significant share sale as Suneetha Reddy, part of the promoter group, plans to offload 1.8 million shares for ₹1,394.5 crore. The block deal, managed by Morgan Stanley, sets a floor price of ₹7,747 per share—a 2.3% discount to Thursday's close. Market participants will scrutinize the transaction for signals about insider confidence.

Abbott makes strides in diabetes care with the India launch of FreeStyle Libre 2 Plus. The sensor device delivers minute-by-minute glucose readings to smartphones, eliminating manual scans. Automated alerts for abnormal levels could transform management of the condition, offering real-time decision support to patients.

Piramal Pharma Solutions expands its US footprint with a new oral solid dosage facility in Pennsylvania. The dedicated FORM suite strengthens its CDMO capabilities, positioning the company to meet growing demand for complex drug formulations. This strategic investment underscores the sector's shift toward specialized manufacturing platforms.